Neurosynaptic Communication Pvt Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Neurosynaptic Communication Pvt Ltd. - overview
Established
2002
Location
Bangalore, Karnataka, India
Primary Industry
Medical Devices & Equipment
About
Neurosynaptic Communication Pvt Ltd. focuses on digital healthcare and telemedicine solutions, utilizing innovative technologies to enhance healthcare accessibility in underserved regions, leveraging their proprietary ReMeDi® platform. Founded in 2002 in Bangalore, India, Neurosynaptic Communication Pvt Ltd. (NCPL) specializes in telemedicine solutions and point-of-care diagnostics.
The company has not undergone any significant pivots. The founders, Rajeev Kumar and Sameer Sawarkar, have experience in the tech sector, with Sameer currently serving as CEO. In October 2016, NCPL raised INR 44. 35 million in Series A funding, marking a significant investment by Axilor Ventures, Indian Angel Network, and Quadria Capital Investment Management.
To date, the company has successfully completed 3 deals, and their total raised amount stands at INR 44. 35 million, with a current valuation of INR 226. 284 million. Neurosynaptic Communications Pvt.
Ltd. (NCPL) specializes in digital healthcare and telemedicine solutions, primarily through its proprietary ReMeDi® platform. The platform integrates advanced point-of-care diagnostic devices with cloud-based healthcare ERP systems and telemedicine technology, aimed at improving healthcare accessibility and affordability, especially in underserved communities. It offers a comprehensive suite of services including remote primary screening and consultations, which facilitate efficient healthcare management.
NCPL targets rural and remote populations across Asia, Africa, and the United States, enhancing access to healthcare for marginalized groups. They collaborate with entities such as the HCL Foundation and the Bill & Melinda Gates Foundation to implement extensive digital health initiatives. In 2023, NCPL reported revenue of INR 1,341,255. 20 and an EBITDA of INR 125,562.
The company's revenue primarily comes from partnerships with government organizations and non-profits, through which they provide healthcare technology solutions and telemedicine services on a contract basis. Their business model includes B2B relationships where they sell ReMeDi® diagnostic solutions and telemedicine services to healthcare providers in underserved regions. Key revenue streams include service contracts, licensing agreements, and ongoing support associated with their technology solutions. Neurosynaptic Communication Pvt Ltd.
plans to leverage its recent funding from the Series A round in October 2016, which raised INR 44. 35 million, to enhance its product offerings and expand its market reach. They are focused on the development of new products to enhance their ReMeDi® platform, aiming for diverse healthcare diagnostics applications. Additionally, the company is exploring expansion into new geographic markets, particularly targeting regions in Africa and South Asia by 2025, to extend their impact in digital healthcare solutions.
The funding will be utilized to support these initiatives, ensuring that NCPL continues to innovate and provide essential healthcare services in underserved communities.
Current Investors
e-Zest Solutions Limited, Indian Angel Network, Quadria Capital Investment Management
Primary Industry
Medical Devices & Equipment
Sub Industries
Medical Equipment Distributors, Medical Software
Website
www.neurosynaptic.com
Company Stage
Series A
Total Amount Raised
Subscriber access only
Neurosynaptic Communication Pvt Ltd. - timeline of key events
Neurosynaptic Communication Pvt Ltd. - financials
| Fiscal Year Ended | Mar 31, 2012 | Mar 31, 2013 | Mar 31, 2014 | Mar 31, 2015 | Mar 31, 2016 | Mar 31, 2017 | Mar 31, 2018 | Mar 31, 2019 | Mar 31, 2020 | Mar 31, 2021 | Mar 31, 2022 | Mar 31, 2023 | Mar 31, 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 12,218,824 | 32,204,529 | 29,706,178 | 24,353,290 | 11,791,589 | 6,322,122 | 14,979,246 | 17,484,498 | 19,907,529 | 39,502,335 | - | - | - |
| % Revenue Growth (YoY) | - | 163.6% | (7.8%) | (18.0%) | (51.6%) | (46.4%) | 136.9% | 16.7% | 13.9% | 98.4% | - | - | - |
| EBITDA (USD) | (2,298,953) | 3,675,020 | 4,398,015 | 3,467,505 | (4,757,951) | (14,731,113) | (9,393,248) | (5,491,450) | (6,696,447) | 6,912,228 | - | - | - |
| Operating Income (USD) | (2,605,308) | 3,405,817 | 4,155,019 | 3,075,300 | (5,161,471) | (15,121,171) | (10,633,343) | (6,874,672) | (7,433,905) | 6,516,259 | - | - | - |
| Operating Margin | (21.3%) | 10.6% | 14.0% | 12.6% | (43.8%) | (239.2%) | (71.0%) | (39.3%) | (37.3%) | 16.5% | - | - | - |
| % EBITDA Margin | (18.8%) | 11.4% | 14.8% | 14.2% | (40.4%) | (233.0%) | (62.7%) | (31.4%) | (33.6%) | 17.5% | - | - | - |
| NET Income (USD) | (4,429,834) | 1,028,585 | 3,049,776 | 1,326,461 | (6,968,820) | (16,248,103) | (11,813,735) | (9,047,090) | (8,623,647) | 4,131,615 | - | - | - |
| % Net Margin | (36.3%) | 3.2% | 10.3% | 5.4% | (59.1%) | (257.0%) | (78.9%) | (51.7%) | (43.3%) | 10.5% | - | - | - |
Neurosynaptic Communication Pvt Ltd. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.